|Day's Range||106.42 - 106.68|
|52 Week Range||92.25 - 106.95|
|PE Ratio (TTM)||-13.21|
|Expense Ratio (net)||0.47%|
Allergan (AGN) is set to release its 1Q17 earnings on May 9, 2017. Analysts’ estimates show EPS at $3.30 on revenues of $3.53 billion for 1Q17.
To better understand the factors affecting growth, let's take a look at Pfizer's performance in US markets and beyond in 1Q17.
For the European markets, GSK's revenues are expected to grow in 1Q17, mainly due to increase in sales of wellness products like Voltaren and the Sensodyne products portfolio.